R
Riccardo Ponzone
Researcher at University of Turin
Publications - 146
Citations - 4364
Riccardo Ponzone is an academic researcher from University of Turin. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 38, co-authored 137 publications receiving 3881 citations. Previous affiliations of Riccardo Ponzone include The Royal Marsden NHS Foundation Trust.
Papers
More filters
Journal ArticleDOI
Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging.
Laura Martincich,Filippo Montemurro,Giovanni De Rosa,Vincenzo Marra,Riccardo Ponzone,Stefano Cirillo,Marco Gatti,Nicoletta Biglia,Ivana Sarotto,Piero Sismondi,Daniele Regge,Massimo Aglietta +11 more
TL;DR: Although in this study tumor volume reduction after two cycles had the strongest predictive value, DCE-MRI has the potential to provide functional parameters that could be integrated to optimize neoadjuvant chemotherapy strategies.
Journal ArticleDOI
Correlations between diffusion-weighted imaging and breast cancer biomarkers
Laura Martincich,Veronica Deantoni,Ilaria Bertotto,Stefania Redana,Franziska Kubatzki,Ivana Sarotto,Valentina Rossi,Michele Liotti,Riccardo Ponzone,Massimo Aglietta,Daniele Regge,Filippo Montemurro +11 more
TL;DR: ADC values vary significantly according to biological tumour features, suggesting that cancer heterogeneity influences imaging parameters, and DWI may identify biological heterogeneity of breast neoplasms.
Journal ArticleDOI
Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival
C. Sfiligoi,Annarita de Luca,Ilaria Cascone,Valentina Sorbello,Luca Fuso,Riccardo Ponzone,Nicoletta Biglia,Enrica Audero,Riccardo Arisio,Federico Bussolino,Piero Sismondi,Michele De Bortoli +11 more
TL;DR: Data suggest a possible role of ANG2 as a prognostic factor for primary breast cancer and univariate and multivariate survival analysis showed significant and independent association between ANG2 mRNA level and both disease‐free and overall survival.
Journal Article
Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer.
He Yu,Maurizia Giai,Eleftherios P. Diamandis,Dionyssios Katsaros,Donald J.A. Sutherland,Michael A. Levesque,R. Roagna,Riccardo Ponzone,P. Sismondi +8 more
TL;DR: This study suggests that IR-PSA is an independent favorable prognostic marker for breast cancer and may be used to identify a subgroup of estrogen receptor-negative and/or node-positive patients who have good prognoses.
Journal ArticleDOI
miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1
Daniela Cimino,Cristiano De Pittà,Francesca Orso,Matteo Zampini,Silvia Casara,Elisa Penna,Elena Quaglino,Marco Forni,C. Damasco,Eva Pinatel,Riccardo Ponzone,Chiara Romualdi,Cathrin Brisken,Michele De Bortoli,Nicoletta Biglia,Paolo Provero,Gerolamo Lanfranchi,Daniela Taverna +17 more
TL;DR: In this paper, the role of microRNAs (miRs) during malignancy was analyzed in 77 primary breast carcinomas and identified 16 relapse-associated miRs that correlate with survival and/or distinguish tumor subtypes in different datasets.